Thailand’s Food and Drug Administration (FDA) has approved the distribution of the AstraZeneca coronavirus vaccination for emergency use and the first 50,000 doses of it will arrive in Thailand in February.
FDA secretary-general Paisarn Dunkum announced yesterday, January 21st, that the approval was granted to AstraZeneca on Wednesday after receiving more than 10,000 pages of documents from the British company for registration for emergency use on December 22, 2020.
The approval allows the first 50,000 doses of the vaccine to arrive in Thailand in February. The import license and vaccine registration will be valid for one year. More vaccines, containing up to 150,000 doses, will be shipped in March and April, according to Paisarn.
The Department of Medical Sciences will conduct a random test on the doses once they arrive in Thailand prior to the official distribution to the public.
Regarding domestic vaccine manufacturing, approximately a million doses will be produced by Siam Bioscience under an agreement with AstraZeneca and will be available for Thai people by May, the secretary-general stated.
Join the discussion in our Facebook group https://www.facebook.com/groups/438849630140035/or in the comments below.
Want to advertise with us or inquire about us promoting your business, event, charity or local sport, etc? E-mail us at Sales@ThePattayaNews.com
Have a General news tip, press release, question, comment, etc? We are not interested in SEO proposals. Mail us at Pattayanewseditor@gmail.com